576 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 12 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
HPD4-hydroxyphenylpyruvate dioxygenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nuclear specklesGroup enriched
HPRT1Hypoxanthine phosphoribosyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolExpressed in all
HRH1Histamine receptor H1FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cytosol
Mixed
HRH2Histamine receptor H2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HRH3Histamine receptor H3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HSD3B1Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
HTR1A5-hydroxytryptamine receptor 1ADisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
HTR1B5-hydroxytryptamine receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
HTR1D5-hydroxytryptamine receptor 1DFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
HTR1E5-hydroxytryptamine receptor 1EFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
HTR1F5-hydroxytryptamine receptor 1FFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
HTR2A5-hydroxytryptamine receptor 2AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR2B5-hydroxytryptamine receptor 2BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
NucleoplasmTissue enhanced
HTR2C5-hydroxytryptamine receptor 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
HTR3A5-hydroxytryptamine receptor 3AFDA approved drug targets
Predicted membrane proteins
Transporters
Group enriched
HTR3B5-hydroxytryptamine receptor 3BFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR3C5-hydroxytryptamine receptor 3CFDA approved drug targets
Predicted membrane proteins
Tissue enhanced
HTR3D5-hydroxytryptamine receptor 3DFDA approved drug targets
Predicted membrane proteins
Transporters
Not detected
HTR3E5-hydroxytryptamine receptor 3EFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR45-hydroxytryptamine receptor 4FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
HTR65-hydroxytryptamine receptor 6FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Not detected
HTR75-hydroxytryptamine receptor 7FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
RAS pathway related proteins
Nuclear speckles
Plasma membrane
Cytosol
Group enriched
ICAM1Intercellular adhesion molecule 1Cancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol
Expressed in all
IDEInsulin degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Expressed in all
IFNGInterferon gammaCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enhanced
IKBKBInhibitor of nuclear factor kappa B kinase subunit betaCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
CytosolMixed
IL1BInterleukin 1 betaCancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
IMPDH1Inosine monophosphate dehydrogenase 1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Cytosol
Rods & Rings
Expressed in all
IMPDH2Inosine monophosphate dehydrogenase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Cytosol
Rods & Rings
Expressed in all
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
VesiclesExpressed in all
ITGA2BIntegrin subunit alpha 2bCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGB3Integrin subunit beta 3Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
JAK1Janus kinase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
JAK2Janus kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Focal adhesion sites
Mixed
JAK3Janus kinase 3Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
JUNJun proto-oncogene, AP-1 transcription factor subunitCancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Transcription factors
NucleoplasmExpressed in all
KCNA1Potassium voltage-gated channel subfamily A member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNA10Potassium voltage-gated channel subfamily A member 10FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Cytosol
Not detected
KCNA2Potassium voltage-gated channel subfamily A member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNA3Potassium voltage-gated channel subfamily A member 3FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNA4Potassium voltage-gated channel subfamily A member 4FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNA5Potassium voltage-gated channel subfamily A member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNA7Potassium voltage-gated channel subfamily A member 7FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
KCNB1Potassium voltage-gated channel subfamily B member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium voltage-gated channel subfamily B member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Plasma membrane
Midbody
Tissue enhanced
KCNC1Potassium voltage-gated channel subfamily C member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nucleus
Nuclear membrane
Vesicles
Cytosol
Tissue enriched
KCNC2Potassium voltage-gated channel subfamily C member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Cytosol
Tissue enriched
KCNC3Potassium voltage-gated channel subfamily C member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
« prev | Page of 12 | next »